Role of nicotinic receptors and acetylcholine in mucous cell metaplasia, hyperplasia, and airway mucus formation in vitro and in vivo.
Role of nicotinic receptors and acetylcholine in mucous cell metaplasia, hyperplasia, and airway mucus formation in vitro and in vivo.
复制标题
DOI:
10.1016/j.jaci.2012.04.002
复制
发表时间:
2012-09
影响因子:
14.2
通讯作者:
Sopori, Mohan L.
中科院分区:
文献类型:
--
作者:
Gundavarapu, Sravanthi;Wilder, Julie A.;Mishra, Neerad C.;Rir-sima-ah, Jules;Langley, Raymond J.;Singh, Shashi P.;Saeed, Ali Imran;Jaramillo, Richard J.;Gott, Katherine M.;Pena-Philippides, Juan Carlos;Harrod, Kevin S.;McIntosh, J. Michael;Buch, Shilpa;Sopori, Mohan L.
关键词:
Airway mucus hypersecretion is a key pathophysiological feature in number of lung diseases. Cigarette smoke/nicotine and allergens are strong stimulators of airway mucus; however, the mechanism of mucus modulation is unclear. Characterize the pathway by which cigarette smoke/nicotine regulates airway mucus and identify agents that decrease airway mucus. IL-13 and gamma-aminobutyric acid receptors (GABAARs) are implicated in airway mucus. We examined the role of IL-13 and GABAARs in nicotine-induced mucus formation in normal human bronchial epithelial (NHBE) and A549 cells, and secondhand cigarette smoke and/or ovalbumin-induced mucus formation in vivo. Nicotine promotes mucus formation in NHBE cells; however, the nicotine-induced mucus formation is independent of IL-13 but sensitive to the GABAAR antagonist picrotoxin (PIC). Airway epithelial cells express α7/α9/α10 nicotinic acetylcholine receptors (nAChRs) and specific inhibition or knockdown of α7- but not α9/α10-nAChRs abrogates mucus formation in response to nicotine and IL-13. Moreover, addition of acetylcholine or inhibition of its degradation increases mucus in NHBE cells. Nicotinic but not muscarinic receptor antagonists block allergen or nicotine/cigarette smoke-induced airway mucus formation in NHBE cells and/or in mouse airways. Nicotine-induced airway mucus formation is independent of IL-13 and α7-nAChRs are critical in airway mucous cell metaplasia/hyperplasia and mucus production in response to various pro-mucoid agents, including IL-13. In the absence of nicotine, acetylcholine may be the biological ligand for α7-nAChRs to trigger airway mucus formation. α7-nAChRs are downstream of IL-13 but upstream of GABAARα2 in the MUC5AC pathway. Acetylcholine and α-7-nAChRs may serve as therapeutic targets to control airway mucus.
登录
查看更多内容
影响因子:
6.1
作者:
Lips, Katrin S.;Luehrmann, Anke;Kummer, Wolfgang
通讯作者:
Kummer, Wolfgang
DOI:
10.4049/jimmunol.0902227
发表时间:
2010-07-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Mishra NC;Rir-sima-ah J;Boyd RT;Singh SP;Gundavarapu S;Langley RJ;Razani-Boroujerdi S;Sopori ML
通讯作者:
Sopori ML
影响因子:
5.5
作者:
Fucile, S;Sucapane, A;Eusebi, F
通讯作者:
Eusebi, F
DOI:
10.1165/rcmb.2010-0109oc
发表时间:
2011-02-01
影响因子:
6.4
作者:
Fu, Xiao Wen;Wood, Kelsey;Spindel, Eliot R.
通讯作者:
Spindel, Eliot R.
影响因子:
2.9
作者:
Ellison, M;Haberlandt, C;Olivera, BM
通讯作者:
Olivera, BM